Nuttapong Ngamphaiboon

9.0k total citations
73 papers, 896 citations indexed

About

Nuttapong Ngamphaiboon is a scholar working on Oncology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nuttapong Ngamphaiboon has authored 73 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 25 papers in Otorhinolaryngology and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nuttapong Ngamphaiboon's work include Head and Neck Cancer Studies (25 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lung Cancer Research Studies (11 papers). Nuttapong Ngamphaiboon is often cited by papers focused on Head and Neck Cancer Studies (25 papers), Cancer Immunotherapy and Biomarkers (18 papers) and Lung Cancer Research Studies (11 papers). Nuttapong Ngamphaiboon collaborates with scholars based in Thailand, United States and Malaysia. Nuttapong Ngamphaiboon's co-authors include Poompis Pattaranutaporn, Tracey L. O’Connor, Noppadol Larbcharoensub, Danny Rischin, Ekaphop Sirachainan, Natini Jinawath, Wan Zamaniah Wan Ishak, Tamara Rordorf, Makoto Tahara and Thorsten Fuereder and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Nuttapong Ngamphaiboon

69 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuttapong Ngamphaiboon Thailand 17 515 247 223 180 171 73 896
Hung-Ming Wang Taiwan 19 270 0.5× 423 1.7× 257 1.2× 230 1.3× 271 1.6× 25 1.1k
B.K. Mohanti India 15 252 0.5× 292 1.2× 320 1.4× 211 1.2× 305 1.8× 58 994
You‐Jian He China 14 508 1.0× 73 0.3× 204 0.9× 110 0.6× 202 1.2× 30 807
Laurence Digue France 16 343 0.7× 245 1.0× 250 1.1× 151 0.8× 259 1.5× 57 927
Ilaria Imarisio Italy 15 317 0.6× 54 0.2× 489 2.2× 351 1.9× 59 0.3× 40 954
Leung Li Hong Kong 14 209 0.4× 58 0.2× 104 0.5× 132 0.7× 109 0.6× 33 571
CC Yau China 11 474 0.9× 395 1.6× 180 0.8× 71 0.4× 357 2.1× 30 980
Xiaochen Shu China 12 282 0.5× 40 0.2× 133 0.6× 201 1.1× 90 0.5× 41 724
Metin Özkan Türkiye 16 507 1.0× 52 0.2× 366 1.6× 182 1.0× 166 1.0× 100 925
Suresh C. Sharma India 20 175 0.3× 99 0.4× 196 0.9× 155 0.9× 419 2.5× 70 1.2k

Countries citing papers authored by Nuttapong Ngamphaiboon

Since Specialization
Citations

This map shows the geographic impact of Nuttapong Ngamphaiboon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuttapong Ngamphaiboon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuttapong Ngamphaiboon more than expected).

Fields of papers citing papers by Nuttapong Ngamphaiboon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuttapong Ngamphaiboon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuttapong Ngamphaiboon. The network helps show where Nuttapong Ngamphaiboon may publish in the future.

Co-authorship network of co-authors of Nuttapong Ngamphaiboon

This figure shows the co-authorship network connecting the top 25 collaborators of Nuttapong Ngamphaiboon. A scholar is included among the top collaborators of Nuttapong Ngamphaiboon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuttapong Ngamphaiboon. Nuttapong Ngamphaiboon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reungwetwattana, Thanyanan, et al.. (2025). EPHX1 and ERCC2 polymorphisms are associated with cisplatin-induced nephrotoxicity and prognosis in Thai cancer patients. PLoS ONE. 20(6). e0324699–e0324699.
2.
Tahara, Makoto, Richard Greil, Danny Rischin, et al.. (2025). Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study. European Journal of Cancer. 221. 115395–115395. 6 indexed citations
3.
4.
Petsuksiri, Janjira, et al.. (2024). Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy. JCO Global Oncology. 10(10). e2300119–e2300119. 1 indexed citations
5.
6.
Ngamphaiboon, Nuttapong, Arunee Dechaphunkul, Chanida Vinayanuwattikun, et al.. (2023). 891P Changing landscape of head and neck squamous cell carcinoma (HNSCC) treatment and survival in Thailand: A 13-year multicenter retrospective study of 6,319 patients. Annals of Oncology. 34. S570–S570.
7.
Jinawath, Natini, et al.. (2023). Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma. JCO Precision Oncology. 7(7). e2300003–e2300003.
8.
Kim, Tae Min, Nuttapong Ngamphaiboon, Ki Hyeong Lee, et al.. (2023). 629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoint inhibitor. SHILAP Revista de lepidopterología. A1808–A1808. 1 indexed citations
9.
Ngamphaiboon, Nuttapong, et al.. (2023). A Phase I Study of the CDK4/6 Inhibitor Palbociclib in Combination with Cetuximab and Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 30(2). 294–303. 6 indexed citations
10.
11.
Ngamphaiboon, Nuttapong, et al.. (2022). Immunotherapy and Biomarkers in Sarcoma. Current Treatment Options in Oncology. 23(3). 415–438. 15 indexed citations
12.
13.
Jinawath, Natini, et al.. (2021). Plasma extracellular vesicle microRNA‐491‐5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma. Cancer Science. 112(10). 4257–4269. 22 indexed citations
14.
Sawangjit, Ratree, et al.. (2020). Efficacy and safety of pharmacological cachexia interventions: systematic review and network meta-analysis. BMJ Supportive & Palliative Care. 11(1). 75–85. 21 indexed citations
15.
Burtness, Barbara, Kevin J. Harrington, Richard Greil, et al.. (2018). KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Annals of Oncology. 29. viii729–viii729. 97 indexed citations
16.
17.
Larbcharoensub, Noppadol, et al.. (2016). Prevalence, pattern, and impact of PD-L1 expression and HPV-status in head and neck squamous cell carcinoma. Annals of Oncology. 27. vi337–vi337. 7 indexed citations
18.
Ngamphaiboon, Nuttapong, Grace K. Dy, Wen Wee, et al.. (2014). A phase I study of the histone deacetylase (HDAC) inhibitor entinostat, in combination with sorafenib in patients with advanced solid tumors. Investigational New Drugs. 33(1). 225–232. 38 indexed citations
19.
Ngamphaiboon, Nuttapong, et al.. (2014). A phase II randomized, double-blind placebo-controlled trial of an antiemetic, 6-gingerol in solid tumor patients receiving moderately to highly emetogenic adjuvant chemotherapy.. Journal of Clinical Oncology. 32(15_suppl). 9647–9647. 2 indexed citations
20.
Ngamphaiboon, Nuttapong, et al.. (2011). Osteonecrosis of The Jaw: Dental Outcomes in Metastatic Breast Cancer Patients Treated With Bisphosphonates With/Without Bevacizumab. Clinical Breast Cancer. 11(4). 252–257. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hung-Ming Wang Breakdown of academic impact, for papers by B.K. Mohanti Breakdown of academic impact, for papers by You‐Jian He Breakdown of academic impact, for papers by Laurence Digue Breakdown of academic impact, for papers by Ilaria Imarisio Breakdown of academic impact, for papers by Leung Li Breakdown of academic impact, for papers by CC Yau Breakdown of academic impact, for papers by Xiaochen Shu Breakdown of academic impact, for papers by Metin Özkan Breakdown of academic impact, for papers by Suresh C. Sharma
Rankless by CCL
2026